Price:
Rs. 7,500.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: D0043
Frequently Asked Questions (FAQ's):
What does the DPD Gene Detection test include?
This test screens for mutations in the DPD gene that may impair enzyme function and affect fluoropyrimidine drug metabolism.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated molecular techniques such as PCR and sequencing to detect DPD gene mutations accurately.
Who should take this test?
Patients scheduled for chemotherapy with fluoropyrimidines, or those with prior severe drug reactions, may be advised to undergo this test.
What sample type is required?
An EDTA anticoagulated blood sample is required for high-quality DNA extraction and precise genetic analysis.
Why is detecting DPD mutations important?
DPD gene mutations can lead to severe toxicity from fluoropyrimidine chemotherapy; identifying them allows safe dosing and personalized treatment planning.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows strict quality control, validated molecular protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow physician instructions for sample collection.
How soon are results available?
Turnaround time may vary depending on the analysis method, but Metropolis Healthcare provides timely and comprehensive reports to guide clinical decisions.